Fill in the form below and our experts will get back to you within 1 business day.
Accelerate your research with CRISPR-Cas9 mediated gene knockout cell lines manufactured to your exact specifications. From single-gene knockouts to complex multiplexed editing, we deliver validated, sequence-verified knockout models with industry-leading efficiency.
Trusted by leading research and pharmaceutical institutions
Frameshift or fragment deletion strategies
Dual or triple gene editing
Cre-lox system for temporal control
Our CRISPR-Cas9 powered platform delivers validated knockout cell lines with complete molecular and phenotypic characterization.
Our proprietary multi-guide CRISPR strategy employs multiple spatially coordinated sgRNAs targeting the same gene. This approach ensures complete protein disruption through fragment deletion, achieving higher knockout efficiency than single-guide methods.
Every knockout cell line undergoes rigorous multi-level verification including Sanger sequencing, and optional Western blot and functional assays. We deliver clonal populations with confirmed homozygous knockouts.
Automated optimization for difficult-to-edit cell lines including primary cells and iPSCs.
Frameshift, fragment deletion, or conditional knockout strategies tailored to your research.
KO clones, wild-type controls, STR reports, and detailed experimental documentation.
Get expert consultation and a customized quote for your specific requirements.
Our optimized platform combines multi-guide design with automated cell line optimization for superior knockout efficiency.
Our bioinformatics team designs up to 3 spatially coordinated sgRNAs targeting early exons for maximal frameshift probability and fragment deletion.
Ribonucleoprotein delivery of Cas9-sgRNA complexes ensures rapid editing with minimal unwanted DNA insertions and reduced immune response.
Our automated platform tests 200+ conditions for each cell line to identify optimal transfection parameters and maximize knockout efficiency.
Variable knockout efficiency depending on editing outcome
Consistent fragment deletion for complete protein loss
Comprehensive specifications for all knockout service options.
| Parameter | Specification |
|---|---|
| CRISPR System | CRISPR-Cas9 (SpCas9) with multi-guide strategy |
| Guide RNA Design | Up to 3 coordinated sgRNAs targeting early exons |
| Delivery Method | RNP (Ribonucleoprotein) complex electroporation |
| Cell Line Options | 700+ validated cell lines; custom optimization available |
| Knockout Types | Frameshift, Fragment deletion, Conditional (Cre-lox) |
| Editing Options | Single gene, Double knockout, Triple knockout |
| Verification Methods | Sanger sequencing, PCR, (Optional) Western blot |
| Quality Control | STR authentication, Mycoplasma testing included |
| Deliverables | Validated KO clone(s), wild-type control, full documentation |
Success rate for standard cell lines
Validated cell line options
Editing efficiency typically achieved
From design to delivery, our streamlined workflow ensures reliable results.
Our scientific team evaluates your target gene, cell line, and research goals to recommend the optimal knockout strategy.
Bioinformatics analysis identifies up to 3 optimal guide sequences targeting early exons for maximum knockout probability.
For difficult-to-edit cell lines, we perform automated optimization testing 200+ conditions to maximize editing efficiency.
Cas9-sgRNA RNP complexes are delivered via electroporation. Single-cell cloning generates homogeneous knockout populations.
Sanger sequencing, PCR analysis, and optional Western blot confirm successful homozygous knockout. STR and mycoplasma testing ensure cell line integrity.
Validated knockout clone(s), wild-type control cells, and comprehensive documentation including sequencing data are shipped to you.
Gene knockout cell lines support research across multiple disciplines.
Knockout cell lines provide definitive evidence for gene function in drug target identification and validation workflows. Remove target expression to confirm mechanism of action and identify potential toxicity.
Gene knockout provides the gold standard for studying gene function by eliminating protein expression completely, unlike RNA interference which only reduces expression temporarily.
Knockout cell lines mimic genetic loss-of-function mutations found in human diseases, enabling research into disease mechanisms and therapeutic interventions.
Trusted by researchers worldwide for quality and reliability.
"The multi-guide strategy delivered complete protein knockout in our difficult-to-edit primary T cells. Western blot confirmed zero target expression. Exactly what we needed for our immunotherapy project!"
"Excellent communication throughout the project. The team provided valuable recommendations for our conditional knockout strategy. The Sanger sequencing data was comprehensive and ready for publication."
"We've relied on this service for multiple drug discovery projects. Consistent quality, on-time delivery, and professional technical support every time. Our go-to partner for knockout cell lines."
References supporting our gene knockout technologies and applications.
Lin SC, Haga K, Zeng XL, Estes MK, et al. (2022) Nature Protocols
View DOITashiro S, Nakanishi K, Kiyonari H, et al. (2023) Cell Reports Methods
View DOISaito AC, Higashi T, Chiba H (2024) STAR Protocols
View DOILu J (2023) Current Protocols
View DOIHu J, et al. (2023) STAR Protocols
View DOIFind answers to common questions about our gene knockout services.
Knockout (KO) permanently eliminates gene expression at the DNA level, resulting in complete absence of the target protein. Knockdown (KD) using siRNA/shRNA temporarily reduces gene expression without altering the genome. KO provides definitive loss-of-function evidence and is stable across cell generations, while KD effects are transient (typically 3-7 days) and may have incomplete silencing.
We use multiple validation methods: (1) Sanger sequencing of the targeted region to confirm indels, (2) PCR analysis to detect fragment deletions, (3) Western blot to confirm absence of protein expression, and (4) functional assays where applicable. Every delivery includes Sanger sequencing data and detailed QC reports.
Yes. Our automated optimization platform tests 200+ conditions for each cell line to identify optimal transfection parameters. We have successfully generated knockouts in primary cells, iPSCs, neurons, and other traditionally difficult cell types. Contact us to discuss your specific cell line requirements.
We offer three main strategies: (1) Frameshift knockout - single or multiple sgRNAs create indels causing frameshift mutations, (2) Fragment deletion - dual sgRNAs delete a portion of the coding sequence for complete knockout, and (3) Conditional knockout - Cre-lox system for temporal or tissue-specific gene inactivation.
Standard service delivers validated clonal cell lines (single-cell derived) with confirmed homozygous knockout. We also offer cell pool options for faster delivery when clonal isolation is not required. Cell pools typically achieve >50% knockout efficiency and can be used for initial screening or further clonal selection.
All deliveries include: Sanger sequencing validation, STR (Short Tandem Repeat) authentication to confirm cell line identity, mycoplasma testing to ensure contamination-free cells, and detailed experimental documentation. Optional add-ons include Western blot verification, off-target analysis, and expression stability testing.
Simply submit your target gene and cell line information through our quote request form or contact us directly. Our scientific team will evaluate your requirements and recommend the optimal knockout strategy. We provide free technical consultation to ensure your project design meets research goals.
Get a customized quote for your Gene Knock-in Services project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.